News
-
-
-
COMMUNIQUÉ DE PRESSE
Financial year 2024 – Implenia achieves targets, further increases profitability and consistently implements strategy
Implenia AG achieves targets in financial year 2024, with increased profitability and successful divisions. Strategy implementation leads to EBIT of CHF 130.5 million and EBIT margin of 3.7% -
COMMUNIQUÉ DE PRESSE
Exercice 2024 : Implenia atteint ses objectifs, continue d'augmenter la rentabilité et applique résolument sa stratégie
Implenia atteint ses objectifs annuels pour 2024 avec une rentabilité accrue et une stratégie de développement solide. Vise un EBIT de CHF ~140 millions pour 2025 -
-
-
-
COMMUNIQUÉ DE PRESSE
Stabilis Solutions Announces Fourth Quarter and Full Year 2024 Results
Stabilis Solutions, Inc. announces strong financial results for Q4 and FY 2024, with net income growth, increased EBITDA, and focus on LNG solutions. Management commentary emphasizes growth opportunities and strategic investments -
COMMUNIQUÉ DE PRESSE
1933 Industries Announces Fourth Quarter and 2024 Year-End Financial Results with Record Revenues of $19.3 Million
1933 Industries Inc. announces fourth quarter and fiscal year 2024 financial results, with record revenues, gross profit increase, and net loss reduction. The company focuses on cannabis cultivation in Nevada -
COMMUNIQUÉ DE PRESSE
MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada
MedMira Inc. (TSXV:MIR) partners with Trimedic Inc. for exclusive distribution of Multiplo® TP/HIV and Reveal® G4 HIV-1/2 rapid antibody tests in Canada, aiming to improve access to rapid diagnostic testing solutions